Division of Teva Pharmaceutical Industries Ltd.
Latest From Ivax Corp.
The pipeline for new drug candidates remains healthy as 2019 begins, with almost 40 novel agents already under FDA review. But the chances of another record-breaking year are threatened by a confluence of safety issues that are putting risk management back in the spotlight – and by the widening ripple effects of the recent US government shutdown.
This week's roundup includes CEO appointments by Eton Pharmaceuticals, the Biotechnology Innovation Organization and Hikma, in addition to various other high-level appointments by Astellas, Akili Interactive Labs and Oxford BioDynamics.
With CEO leadership in the biopharma industry more short-cycled than ever, billionaire entrepreneur Phillip Frost ranks as a competitor for the long game – the last man standing in an endurance test spanning four decades of exposure to every iteration of a fast-changing business model. Frost’s strategy at Opko eschews the approach of most of his CEO peers to seek therapeutic dominance in a narrow band of core competencies.
Five companies in big pharma’s top 20 have come through mergers in the past 10 years or so that changed them significantly. As measured by standard financial performance parameters, the processes at Takeda and Teva (and to some extent, at Allergan) seem relatively smooth and productive. Those at Pfizer and Merck don’t. But it depends on how you look at the numbers.
- Generic Drugs
- Therapeutic Areas
- North America
- Parent & Subsidiaries
Teva Pharmaceutical Industries Ltd.
- Baker Norton Pharmaceuticals Inc.
- Becpharm Ltd.
- Best Generics Inc.
- Flori Roberts Inc.
- Galena SP
- Goldline Laboratories
- Indiana Protein Technologies Inc.
- Institute for Drug Research Ltd.
- IVAX Industries Inc.
- Ivax International GMBH
- Ivax Laboratories Inc.
- Ivax Pharmaceuticals Inc.
- Ivax Pharmaceuticals UK
- Kutnowskie Zaklady Farmaceutyczne Polfa SA
- Laboratoires Merck Sharp & Dohme-Chibret
- Laboratoires MSD-Chibret
- Laboratorio Chile SA
- Laboratorios Elmor SA
- Laboratorios Fustery SA
- Medical Market Specialties Inc.
- Netpharma Scandinavia AB
- Pharmatop Ltd.
- Pharmedix Inc.
- Sackrison and Associates
- Waterford Pharmaceuticals Ltd.
- Willen Drug Co.
- Zenith Laboratories Inc.
- Ivax Corp.
- Senior Management
Phillip Frost, MD, Chmn. & CEO
Thomas E Beier, SVP, Fin. & CFO
Bruce J Wendel, VP, Bus. Dev. & Licensing
Richard Denness, VP, Sales & Mktg.
- Contact Info
Phone: (305) 575-6000
4400 Biscayne Blvd.
Miami, FL 33137-3227
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.